MaxCyte (LON:MXCT) Stock Price Crosses Below 50-Day Moving Average – Time to Sell?

MaxCyte, Inc. (LON:MXCT) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 1.32 and traded as low as GBX 0.77. MaxCyte shares last traded at GBX 0.77, with a volume of 1,773,609 shares traded.

MaxCyte Stock Up 0.5%

The stock has a market capitalization of £780,275.14, a price-to-earnings ratio of -0.02 and a beta of 1.13. The firm has a 50-day moving average of GBX 1.32 and a 200 day moving average of GBX 1.49. The company has a current ratio of 9.81, a quick ratio of 14.38 and a debt-to-equity ratio of 8.59.

About MaxCyte

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.